AI in medicine falls into three interaction levels—assisted, augmented and automated—each producing distinct effects on work, productivity and management. Rather than simply displacing clinicians, the dominant trajectory is toward Human+ professionals who supervise, exercise higher-order judgment and manage exceptions.

Main Finding

The study identifies a three-level taxonomy of human–AI interaction in healthcare (AI-assisted, AI-augmented, AI-automated) that maps to distinct innovation categories, different impacts on human expertise, and divergent implications for innovation management. Across four case studies, AI reshapes medical work by enhancing availability, real-time decision support, or process streamlining, while human expertise remains essential — producing a trajectory toward “Human+” professionals rather than wholesale replacement.

Key Points

• Purpose: To analyze how different forms of AI use in healthcare transform practitioners into Human+ professionals and affect innovation management practices.
• Conceptual frame: Analysis uses Bolton et al. (2018)’s three-dimensional service-innovation framework to interpret service, technology, and organizational dynamics.
• Empirical approach: Multiple qualitative case studies of four AI healthcare applications, chosen to illustrate different AI–human configurations.
• Three interaction levels:
  • AI-assisted — automates highly repetitive tasks (e.g., triage routing, routine image preprocessing). Primary innovation effect: increased service availability and throughput; impact: frees clinician time but requires oversight and integration into workflows.
  • AI-augmented — supports real-time medical tasks (e.g., decision support during procedures). Primary innovation effect: amplifies human judgment and speed; impact: raises required cognitive skills, changes training needs and coordination practices.
  • AI-automated — streamlines end-to-end processes while keeping humans in supervisory/exception roles (e.g., automated reporting pipelines with human sign-off). Primary innovation effect: process reconfiguration and efficiency gains; impact: shifts roles toward exception management and governance.
• Core insight: Adoption is better framed as evolution to Human+ capabilities (complementarity) rather than simple substitution; innovation management must preserve and cultivate human expertise even as tasks move to AI.
• Limitations: Qualitative, small-sample case approach—interpretive and illustrative rather than statistically generalizable.

Data & Methods

• Design: Qualitative multiple case study.
• Sample: Four AI applications in healthcare selected to represent different configurations of AI–human interaction (details not specified in the abstract).
• Analytical framework: Bolton et al. (2018) three-dimensional framework for service innovation, used to map technological configuration, service processes, and organizational/skill implications.
• Analysis: Cross-case comparison to derive levels of interaction, link them to innovation categories, and infer impacts on human expertise and innovation management.
• Methodological notes: Exploratory interpretive analysis appropriate for theory-building; suggests need for subsequent quantitative validation (productivity, labor-market effects, outcomes).

Implications for AI Economics

• Task structure and labor demand
  • The taxonomy clarifies where substitution vs. complementarity are likely: AI-assisted tasks imply partial substitution of routine work; AI-augmented applications generate complementarities that increase demand for higher cognitive skills; AI-automated systems can shift labor toward monitoring, exception handling, and governance.
  • Predicts compositional shifts in health labor markets (downward demand for some routine roles, upward demand/returns for clinical judgment, coordination and data-literacy skills).
• Productivity and value creation
  • Different interaction levels produce heterogenous productivity gains (throughput increases, faster/safer decisions, process cost reductions). Economic evaluation should be level-specific.
  • Value capture and pricing models will differ (e.g., per-use service expansions for AI-assisted; outcome- or decision-value pricing for AI-augmented; platform/process contracting for AI-automated systems).
• Innovation management and firm strategy
  • Firms and hospitals need differentiated investment and governance strategies by interaction level: emphasis on integration and workflow redesign for AI-assisted; training and decision-support protocols for AI-augmented; process redesign, liability allocation, and oversight systems for AI-automated.
  • R&D and procurement choices should account for complementarities with human capital and the costs of retraining and governance.
• Policy and regulation
  • Regulation should be calibrated to interaction level: stronger oversight and validation for AI-augmented/automated systems that affect clinical decisions; workforce policies (reskilling subsidies, credentialing) to manage transitions toward Human+ roles.
  • Payment systems and incentives (reimbursement, procurement) need to internalize long-run returns to complementary human skills and system-level gains.
• Measurement and research agenda
  • Calls for quantitative follow-ups to estimate causal impacts on productivity, health outcomes, wages, and employment composition across the three interaction levels.
  • Suggests using task-based, matched employer-employee, and provider-level panel data to measure complementarities and redistribution effects.
  • Recommends economic models that incorporate service innovation dynamics (adoption externalities, learning-by-doing, regulation) and heterogenous returns by AI–human configuration.

Overall, the paper provides a practical taxonomy that can help economists and policymakers predict where AI will augment vs. displace healthcare work, prioritize measurement efforts, and design targeted interventions (training, procurement, regulation) to capture productivity gains while preserving essential human expertise.